Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,432,882 papers from all fields of science
Search
Sign In
Create Free Account
Metrizamide
Known as:
D-Glucose, 2-((3-(acetylamino)-5-(acetylmethylamino)-2,4,6-triiodobenzoyl)amino)-2-deoxy-
, Metrizamide [Chemical/Ingredient]
A solute for density gradient centrifugation offering higher maximum solution density without the problems of increased viscosity. It is also used as…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Narrower (2)
Amipak
P297
Broader (1)
Contrast Media
Hypersensitivity
In Blood
agonists
analogs & derivatives
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1984
Highly Cited
1984
Functional and morphological studies on isolated Leydig cells: purification by centrifugal elutriation and metrizamide fractionation.
D. Aquilano
,
M. Dufau
Endocrinology
1984
Corpus ID: 38627171
Rat interstitial cells were fractionated by centrifugal elutriation to facilitate the purification of Leydig cells for analysis…
Expand
1980
1980
Metrizamide cisternography in pituitary and juxtapituitary lesions.
K. Hall
,
V. McAllister
Radiology
1980
Corpus ID: 7404089
Seventy-five suprasellar metrizamide cisternograms were obtained, 25 in normal individuals who had had cervical myelography and…
Expand
Highly Cited
1979
Highly Cited
1979
The murine Kupffer cell. I. Characterization of the cell serving accessory function in antigen-specific T cell proliferation.
L. K. Richman
,
R. Klingenstein
,
J. Richman
,
W. Strober
,
J. Berzofsky
Journal of Immunology
1979
Corpus ID: 38881933
Murine Kupffer cells, the tissue macrophages of the liver, were isolated by collagenase digestion, differential sedimentation…
Expand
1979
1979
Adverse side effects of metrizamide in myelography
H. Gelmers
Neuroradiology
1979
Corpus ID: 1837432
SummaryThe adverse side effects in a series of 439 myelographies with metrizamide were analyzed. The most frequent side effect…
Expand
Highly Cited
1977
Highly Cited
1977
Metrizamide in Angiography
T. Almén
,
E. Boijsen
,
S. Lindell
Acta radiologica: diagnosis
1977
Corpus ID: 37853387
In 20 patients the non-ionic Amipaque (metrizamide) and the ionic Isopaque Cerebral (meglumine/calcium-metrizoate) were injected…
Expand
Highly Cited
1977
Highly Cited
1977
Metrizamide--CSF contrast medium. Analysis of clinical application in 215 patients.
J. Sackett
,
C. Strother
,
C. Quaglieri
,
M. Javid
,
A. Levin
,
T. A. Duff
Radiology
1977
Corpus ID: 24098569
Two-hundred-fifteen patients were evaluated with metrizamide, a new water-soluble contrast agent for use in the subarachnoid…
Expand
Highly Cited
1975
Highly Cited
1975
Lumbar Myelography with Meglumine Iocarmate and Metrizamide
T. Hindmarsh
Acta radiologica: diagnosis
1975
Corpus ID: 40470311
Metrizamide and meglumine iocarmate (Dimer-X), which at present are the contrast media for myelography best tolerated by central…
Expand
Highly Cited
1975
Highly Cited
1975
Myelography with the Non-Ionic Water-Soluble Contrast Medium Metrizamide
T. Hindmarsh
Acta radiologica: diagnosis
1975
Corpus ID: 10251504
Technical problems in myelography with the water-soluble contrast medium, metrizamide are analysed and a technique used for…
Expand
Highly Cited
1973
Highly Cited
1973
Transient Eeg Abnormalities following Lumbar Myelography with Metrizamide
B. Kaada
Acta radiologica. Supplementum
1973
Corpus ID: 36911507
It is recognized that certain water-soluble contrast media used in neuro radiology have an epileptogenic action when injected…
Expand
1973
1973
Acute Toxicity Tests of Metrizamide
S. Salvesen
Acta radiologica. Supplementum
1973
Corpus ID: 34103174
By the introduction of a new contrast medium acute toxicity tests have always been regarded as very important parameters. In the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required